<DOC>
	<DOCNO>NCT00366548</DOCNO>
	<brief_summary>The purpose study assess safety , tolerability immunogenicity 13-valent pneumococcal conjugate ( 13vPnC ) vaccine manufacture Polysorbate 80 compare 13-valent pneumococcal conjugate ( 13vPnC ) manufacture without Polysorbate 80 give concomitantly routine paediatric vaccination .</brief_summary>
	<brief_title>Study Evaluate 13-valent Pneumococcal Conjugate Vaccine Infants</brief_title>
	<detailed_description />
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>Inclusion criterion : 1 . Aged 2 month ( 42 98 day ) time enrollment . 2 . Available entire study period whose parent ( ) /legal guardian ( ) could reach telephone . 3 . In good health determine medical history , physical examination , judgment investigator . 4 . Parent ( ) /legal guardian ( ) able complete relevant study procedure study participation . Exclusion criterion : 1 . Previous vaccination license investigational pneumococcal vaccine . 2 . Previous vaccination Hib conjugate , diphtheria , tetanus , pertussis , polio vaccine . 3 . A previous anaphylactic reaction vaccine vaccinerelated component . 4 . Contraindication vaccination Hib conjugate , diphtheria , tetanus , pertussis , polio , hepatitis B , pneumococcal vaccine . 5 . Bleeding diathesis condition associate prolonged bleeding time would contraindicate intramuscular injection . 6 . Known suspected immune deficiency suppression . 7 . History cultureproven invasive disease cause S pneumoniae . 8 . Major know congenital malformation serious chronic disorder . 9 . Significant neurological disorder history seizure ( include febrile seizure ) , significant stable evolve disorder ( cerebral palsy , encephalopathy , hydrocephalus ) , significant disorder . This include resolve syndrome birth trauma Erb palsy . 10 . Receipt blood product Î³globulin ( include hepatitis B immunoglobulin monoclonal antibody [ eg , Synagis ] ) .</criteria>
	<gender>All</gender>
	<minimum_age>42 Days</minimum_age>
	<maximum_age>98 Days</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Vaccine</keyword>
	<keyword>Infant</keyword>
</DOC>